Advertisement · 728 × 90
#
Hashtag
#Ventavia
Advertisement · 728 × 90

#PfizerDocs
Comme je le disais il y a 6 mois, aucune raison que #Ventavia fût un cas isolé.
Ce thread de @Jikkyleaks, nous apprend l'existence de 2 sites très surprenants : 1231 & 4444


x.com/felicittina/st… threadreaderapp.com/thread/1523617…

0 0 0 1
Scientists Doing Dangerous Virus Research Cry Victim To Avoid Public Accountability Afraid of transparency, suspect virus researchers shamelessly exploit actual threat to Chinese researchers.

« Les scientifiques, à la tête de recherches sur les virus dangereux, jouent les victimes pour échapper à leurs responsabilités.»
Article par @thackerpd, l'auteur du papier de @bmj_latest sur les essais #Pfizer #Ventavia.
#Wuhan #Daszak #Fauci

disinformationchronicle.substack.com/p/scientists-d…

0 0 0 0
Open letter from The BMJ to Mark Zuckerberg We are Fiona Godlee and Kamran Abbasi, editors of The BMJ, one of the world’s oldest and most influential general medical journals. We are writing to raise serious concerns about the “fact checking” being undertaken by third party providers on behalf of Facebook/Meta.

Lettre ouverte du @bmj_latest à Mark Zuckerberg, dénonçant les pratiques de Facebook en matière de #FactCheck, notamment par rapport à l'article concernant les essais #Pfizer #Ventavia | The BMJ

bmj.com/content/375/bm…

0 0 0 0
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Paul D Thacker reports In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. “As I’ve said before, we are operating at the speed of science,” Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States.1 But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson (video 1), emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails. Video 1 Whistleblower Brook Jackson tells The BMJ about her experience working on the Pfizer covid-19 vaccine trial On its website Ventavia calls itself the largest privately owned clinical research company in Texas and lists many awards it has won for its contract work.2 But Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, …

9. Is the #Ventavia affair revealed by the #BMJ only a rotten apple in a big basket or a patch that drops on the wall of a toxic sludge tank?
And this only concerns clinical trials, not vaccine production conditions🧐

bmj.com/content/375/bm…

0 0 1 0
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Paul D Thacker reports In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. “As I’ve said before, we are operating at the speed of science,” Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States.1 But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson (video 1), emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails. Video 1 Whistleblower Brook Jackson tells The BMJ about her experience working on the Pfizer covid-19 vaccine trial On its website Ventavia calls itself the largest privately owned clinical research company in Texas and lists many awards it has won for its contract work.2 But Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, …

L'affaire #Ventavia révélée par le #BMJ n'est-elle qu'un grain de sable dans un rouage ou une rustine qui lâche sur la paroi d'un réservoir de boues toxiques?
Et cela ne concerne que les essais cliniques, pas les conditions de production des vaccins🧐

bmj.com/content/375/bm…

0 0 0 0
Post image

#Pfizer #Ventavia cas isolé ?
Graphique éloquent issu du rapport @USGAO du 27/10 sur les inspections menées par la #FDA sur les sites de production biologique.
5⃣8⃣ inspections d'avril 2020 à mars 2021 (0 à l'étranger) contre 1500 les 12 mois précédents…

files.gao.gov/reports/GAO-22…

0 0 1 6

Bon, je crois que l'étude de l'@ONS a été sous-traitée à #Ventavia.
En effet, si on additionne les populations on trouve un total de 39M alors que la population 10+ avoisinerait 50M.
Donc pour l'instant 🗑️

0 0 0 0